IQVIA MedTech

Accelerate MedTech commercialization from insight to impact

Turn data, strategy, and execution into measurable MedTech market success - faster launches, stronger adoption, and sustained performance.
Contact us
Sub Brands MedTech Homepage Commercialization
Explore More
background accent graphic

MedTech commercialization & market access challenges

MedTech commercialization is more complex than ever. Increasing regulatory demands, pricing pressures, competitive dynamics, and operational constraints can lead to delayed launches, approval setbacks, recalls, reduced market access, and lower commercial performance.

IQVIA MedTech helps organizations navigate this complexity through integrated commercial solutions powered by predictive analytics, therapeutic expertise, industry-leading data, and AI-enabled technology. From market access and reimbursement to commercialization and lifecycle execution, we help accelerate adoption, improve efficiency, unlock growth potential, and reduce risk — so your innovation can thrive.

Market assessment & entry

IQVIA MedTech supports early‑stage and expansion‑stage medical device commercialization consulting with robust, MedTech‑specific market intelligence. Our approach reflects real‑world clinical practice, adoption variability, and site‑of‑care dynamics—enabling manufacturers to evaluate opportunity, risk, and readiness with clarity before investing or expanding.
Contact us

Branding & positioning

Effective MedTech commercialization requires positioning that resonates with clinicians, health systems, patients, and payers. IQVIA MedTech helps manufacturers define and validate positioning using need‑gap analysis, competitive intelligence, and stakeholder insight - ensuring value propositions are credible, differentiated, and aligned with MedTech market access and reimbursement expectations.
Contact us

Launch support

IQVIA MedTech enables high‑impact launches by aligning commercial, medical, and access strategies with execution. We help manufacturers navigate the complexity of MedTech market access consulting, reimbursement pathways, and evolving engagement models - while activating targeted launch execution that drives early adoption and sustained growth.
Contact us

Performance measurement

IQVIA MedTech provides continuous visibility into commercial performance using trusted data and advanced analytics. Our performance measurement capabilities help manufacturers understand adoption, penetration, and brand impact - enabling faster, more informed optimization in dynamic MedTech markets.
Contact us

Commercial execution

IQVIA MedTech delivers flexible, scalable MedTech commercialization services that evolve with portfolio needs and customer engagement models. From strategy to execution, we help manufacturers reduce complexity while improving consistency, effectiveness, and speed to market across the lifecycle.

Contact us
Pill Shaped Accent Graphics

MedTech HCP engagement & compliance

Transform HCP engagement

Enable compliant, high‑impact engagement with physicians, surgeons, and healthcare professionals across the medical device lifecycle. IQVIA MedTech helps manufacturers modernize HCP collaboration by combining trusted reference data with purpose‑built digital platforms that simplify compliance, contracting, and payments at global scale.

Outcomes for MedTech manufacturers

  • 97% faster compliance approvals
  • 86% reduction in contracting time
  • 75% faster payments

Powered by IQVIA MedTech solutions

  • OneKey® provides a trusted global foundation for medical device HCP engagement, with data on 25M healthcare professionals across 117 countries and up to 1,000 data elements per profile, enabling accurate identification, targeting, and compliant engagement across commercial and medical interactions.
  • IQVIA MedTech Surgical Collaboration Platform enables compliant, digital collaboration with surgical stakeholders, supporting transparent approvals, efficient contracting, and consistent execution of HCP engagements.
Contact us
IQVIA MedTech Recall and Field Action Support
Manage recalls with speed, control, and confidence
End-to-end management of product recalls and field actions is central to MedTech quality and compliance. IQVIA MedTech’s ISO 9001:2015 certified systems enable global support, digitized response, and onsite remediation, while our centralized tracking and real-time reporting processes streamline regulatory submissions and reduce operational burden.
Learn More
Team reviews analytics and market strategies for biotech asset success and patient outcomes in IQVIA biopharma meeting.

Why MedTech businesses trust us

1600+

Medical device and diagnostics customers across 80+ countries

40+

Years of working with MedTech customers

15+

Therapeutic centers of excellence

1,000+

Diagnostic and surgical procedures covered

25M

Insights into 25M healthcare professionals across 6M organizations

96%

IQVIA MedTech recall programs achieve a 96% overall consignee response rate for field actions and product recalls.

We aim to be MedTech’s partner of choice by helping clients succeed in the market and improve patient outcomes. We do this through solutions designed specifically for MedTech and delivered by the most capable professionals in the industry.
MedTech is a completely unique space within the life science industry. Our experts have decades of experience with MedTech Market Access, Primary Intelligence, Strategy and Data – we translate our breadth of resources into specific solutions for medical device companies.
Todd Schaefer
VP & GM, MedTech Commercial Solutions
Michelle Edwards
VP, Consulting and RWE, IQVIA MedTech

Accelerate your path to MedTech commercialization success

Bringing your innovation to market is a milestone - but sustaining success demands more. Contact the IQVIA MedTech team today.

Talk to a MedTech commercialization expert

Case Study

Case Study: Market Access Success

A medical technology company recently sought to expand global patient access to its minimally invasive therapy for treating a common degenerative spinal condition. To strategically plan international expansion, the company engaged IQVIA MedTech to assess and prioritize markets with the least barriers to entry.

The study aimed to rank countries based on regulatory complexity, reimbursement landscape, market potential, and clinical adoption trends.


The condition in focus primarily affects aging populations, with symptoms caused by the narrowing of spinal nerve passages. Treatment options vary from conservative pain management to invasive surgical procedures. The minimally invasive therapy in question presents an alternative that improves patient outcomes while reducing procedural risks and recovery time. Understanding global market dynamics was essential for identifying the best regions for commercial entry.

Challenge

Regulatory Complexity

The company needed to determine which international markets offered the most favorable conditions for the introduction of its therapy while minimizing regulatory and reimbursement hurdles.

The key challenges included:

  • Regulatory Complexity: Countries had different approval pathways, requiring an in-depth analysis of timelines, documentation, and procedural hurdles.
  • Reimbursement Variability: Identifying how the therapy would be funded in public and private healthcare systems across multiple regions.
  • Market Potential: Assessing the demand for treatment, current treatment practices, and interest from healthcare professionals.
  • Stakeholder Perception: Understanding how key decision-makers, including surgeons, payers, and procurement managers, perceived the therapy in comparison to traditional treatments.
    The complexity of market access strategies required a structured, data-driven approach to prioritize entry into regions where regulatory approval and commercial success could be achieved efficiently.
Solution

Pathways mapped

IQVIA MedTech conducted a Global Market Prioritization Assessment using a multi-faceted approach. The study provided a comprehensive market roadmap, allowing for informed strategic decisions regarding expansion and commercialization:
  1. Market Heatmap Development: Analyzed multiple countries based on regulatory requirements, reimbursement structures, and commercial potential.
  2. Stakeholder Engagement: Interviews were conducted with key opinion leaders, including spine surgeons, anesthesiologists, pain management specialists, and payers, to gauge perceptions and treatment adoption trends.
  3. Regulatory & Reimbursement Analysis: Mapped the approval timelines and reimbursement challenges in each market, determining where the therapy could gain the quickest access.
  4. Competitive Landscape Assessment: Identified existing treatment pathways and gaps that the therapy could address effectively.
Results

Expansion optimized

The market prioritization assessment yielded key insights, successfully guiding the expansion strategy:

High-Priority Markets Identified:
The study highlighted several markets with strong regulatory pathways, favorable reimbursement structures, and significant demand for minimally invasive treatment options.


Secondary Opportunities:
Additional markets were identified with potential but required more complex regulatory and reimbursement navigation.


Challenges in Certain Regions:
Some markets exhibited higher barriers due to restrictive reimbursement policies and lower physician adoption rates.


Regulatory Pathway Clarity:
The study demonstrated that most target markets had manageable regulatory pathways, enabling a structured approach to approvals.


Reimbursement & Adoption Insights:
In many regions, reimbursement policies favored procedures requiring hospitalization, suggesting a need to position the therapy in alignment with market expectations.

Futuristic telemedicine services utilizing AI diagnostic tools to streamline efficient pathways for regulatory approvals and healthcare innovation.
Blog
MedTech Trends Shaping 2026
Explore the top MedTech trends shaping 2026, from AI and real-world evidence to medical device regulation, diagnostics, robotics, and digital health.
POPULAR
Insight Brief
IQVIA MedTech physician surveys reveal how pulsed field ablation is scaling fast
White Paper
Navigating China's MedTech Market
Event/Webinar
AI in MedTech: Lessons from the Front Line
White Paper
The Rise of Robotics in Orthopedics

Our latest thinking on MedTech Commercial Solutions

Blog
Beyond CE marking: why MedTech access challenges differ across sectors
By: Zhen Nie, Rob Haslewood
Case Study
Medical Devices Speaker Programs: A Smarter, Compliant Model with IQVIA MedTech
Webinar
AI in MedTech: Lessons from the Front Line
April 28, 2026
Case Study
Safeguard Your Medical Devices Business with Smarter Channel Data Management
Case Study
Transform Your Medical Devices Contract Management with IQVIA MedTech's 845 Automation
Blog
Global Surgical Trends in Cardiovascular Care: A Data-Driven Comparison of Italy and Colombia
By: Laura Weynants, Sara Chapa, Rob Haslewood
Blog
MedTech Trends Shaping 2026
By: Michelle Edwards, Karen Schuyler, Kyle Biesecker, David Kowalski, Julie Larsen, Joe McGonigle, Reid D’Amico, Gunner Drossel, Raj Stewart, Glenn Stiegman
Blog
Global surgical volume growth trends: what medical device companies need to know in 2026
By: Laura Weynants, Sara Chapa, Rob Haslewood
Blog
The future of diagnostics: Key trends that will shape point-of-care testing by 2030
By: Shikha Sharma, David Kowalski, Robert Haslewood
White Paper
Unlocking Strategic Insights Through Chart Audits in MedTech Market Research
Fact Sheet
Unlock Insights with Global In Vitro Diagnostic Market Data
White Paper
How Big Is the Opportunity? Navigating market sizing in devices and diagnostics
Prev
View all
Next
View all

Explore More

IQVIA MedTech Solutions